A controlled investigation of propofol, thiopentone and methohexitone

This was a randomized study of 180 ASA physical status I and II patients, 60 in each group who received propofol (PROP), 2.5 mg . kg-1, thiopentone (THIO), 4 mg . kg-1, or methohexitone (METH), 1.5 mg . kg-1. Control values, followed by changes after induction and during a 3-min delay before intubat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian journal of anesthesia 1987-09, Vol.34 (5), p.478-483
Hauptverfasser: GOLD, M. I, ABRAHAM, E. C, HERRINGTON, C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 483
container_issue 5
container_start_page 478
container_title Canadian journal of anesthesia
container_volume 34
creator GOLD, M. I
ABRAHAM, E. C
HERRINGTON, C
description This was a randomized study of 180 ASA physical status I and II patients, 60 in each group who received propofol (PROP), 2.5 mg . kg-1, thiopentone (THIO), 4 mg . kg-1, or methohexitone (METH), 1.5 mg . kg-1. Control values, followed by changes after induction and during a 3-min delay before intubation were recorded for the following parameters: heart rate (HR), systolic and diastolic blood pressures (SBP, DBP), respiratory rate (RR), end-tidal CO2 (PETCO2), and induction time (IT). In addition, the incidence of adverse reactions and time for recovery from anaesthesia were noted. The IT (mean +/- SE) was 35 +/- 1 sec for propofol, 35 +/- 1.2 sec for thiopentone and 34 +/- 1.4 sec for methohexitone. Ninety-three per cent of the PROP group fell asleep with one dose and required no additional doses. Fifty per cent of each of the THIO and METH groups required additional agents (p less than 0.05). METH was associated with the highest elevation in HR, PROP the least (p less than 0.05). PROP was associated with the most decrease in SBP and DBP and in addition respiratory depression (p less than 0.05). The incidence of injection pain or excitatory activity was equal in the three groups with the exception that 14 patients who received METH developed hiccoughs while none did in the other groups. PROP was associated with the most rapid recovery, particularly with respect to the orientation time. We conclude that PROP is an effective alternative to barbiturate induction and that the published recommended doses of THIO and METH are often ineffective.
doi_str_mv 10.1007/BF03014354
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF03014354</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3499244</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-9c5f034ef3f17e46dd904772424c28ae1f890d0d092efdfdeff5be59c036e4dd3</originalsourceid><addsrcrecordid>eNpFkEFLAzEUhIMotVYv3oU9eBJXXzbZzeZYS6tCwYuCtyVNXmxku1mSKPrv3dJSeYeBNx8DM4RcUrijAOL-YQEMKGclPyJjymWV11KUx2QMNSvyisL7KTmL8RMA6qqsR2TEuJQF52Myn2badyn4tkWTue4bY3IfKjnfZd5mffC9t769zdLa-R675DvMVGeyDaa1X-OP237OyYlVbcSLvU7I22L-OnvKly-Pz7PpMteMi5RLXVpgHC2zVCCvjJHAhSh4wXVRK6S2lmCGkwVaYw1aW66wlBpYhdwYNiE3u1wdfIwBbdMHt1Hht6HQbKdo_qcY4Ksd3H-tNmgO6L774F_vfRW1am1QnXbxgNVMFIJX7A9tjma7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A controlled investigation of propofol, thiopentone and methohexitone</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>GOLD, M. I ; ABRAHAM, E. C ; HERRINGTON, C</creator><creatorcontrib>GOLD, M. I ; ABRAHAM, E. C ; HERRINGTON, C</creatorcontrib><description>This was a randomized study of 180 ASA physical status I and II patients, 60 in each group who received propofol (PROP), 2.5 mg . kg-1, thiopentone (THIO), 4 mg . kg-1, or methohexitone (METH), 1.5 mg . kg-1. Control values, followed by changes after induction and during a 3-min delay before intubation were recorded for the following parameters: heart rate (HR), systolic and diastolic blood pressures (SBP, DBP), respiratory rate (RR), end-tidal CO2 (PETCO2), and induction time (IT). In addition, the incidence of adverse reactions and time for recovery from anaesthesia were noted. The IT (mean +/- SE) was 35 +/- 1 sec for propofol, 35 +/- 1.2 sec for thiopentone and 34 +/- 1.4 sec for methohexitone. Ninety-three per cent of the PROP group fell asleep with one dose and required no additional doses. Fifty per cent of each of the THIO and METH groups required additional agents (p less than 0.05). METH was associated with the highest elevation in HR, PROP the least (p less than 0.05). PROP was associated with the most decrease in SBP and DBP and in addition respiratory depression (p less than 0.05). The incidence of injection pain or excitatory activity was equal in the three groups with the exception that 14 patients who received METH developed hiccoughs while none did in the other groups. PROP was associated with the most rapid recovery, particularly with respect to the orientation time. We conclude that PROP is an effective alternative to barbiturate induction and that the published recommended doses of THIO and METH are often ineffective.</description><identifier>ISSN: 0832-610X</identifier><identifier>EISSN: 1496-8975</identifier><identifier>DOI: 10.1007/BF03014354</identifier><identifier>PMID: 3499244</identifier><identifier>CODEN: CJOAEP</identifier><language>eng</language><publisher>Toronto, ON: Canadian Anesthesiologists' Society</publisher><subject>Adult ; Anesthesia Recovery Period ; Anesthesia, Intravenous ; Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Blood Pressure - drug effects ; Double-Blind Method ; Heart Rate - drug effects ; Humans ; Medical sciences ; Methohexital - adverse effects ; Methohexital - pharmacology ; Middle Aged ; Neuropharmacology ; Pharmacology. Drug treatments ; Phenols - adverse effects ; Phenols - pharmacology ; Propofol ; Random Allocation ; Respiration - drug effects ; Thiopental - adverse effects ; Thiopental - pharmacology</subject><ispartof>Canadian journal of anesthesia, 1987-09, Vol.34 (5), p.478-483</ispartof><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-9c5f034ef3f17e46dd904772424c28ae1f890d0d092efdfdeff5be59c036e4dd3</citedby><cites>FETCH-LOGICAL-c347t-9c5f034ef3f17e46dd904772424c28ae1f890d0d092efdfdeff5be59c036e4dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8372746$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3499244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GOLD, M. I</creatorcontrib><creatorcontrib>ABRAHAM, E. C</creatorcontrib><creatorcontrib>HERRINGTON, C</creatorcontrib><title>A controlled investigation of propofol, thiopentone and methohexitone</title><title>Canadian journal of anesthesia</title><addtitle>Can J Anaesth</addtitle><description>This was a randomized study of 180 ASA physical status I and II patients, 60 in each group who received propofol (PROP), 2.5 mg . kg-1, thiopentone (THIO), 4 mg . kg-1, or methohexitone (METH), 1.5 mg . kg-1. Control values, followed by changes after induction and during a 3-min delay before intubation were recorded for the following parameters: heart rate (HR), systolic and diastolic blood pressures (SBP, DBP), respiratory rate (RR), end-tidal CO2 (PETCO2), and induction time (IT). In addition, the incidence of adverse reactions and time for recovery from anaesthesia were noted. The IT (mean +/- SE) was 35 +/- 1 sec for propofol, 35 +/- 1.2 sec for thiopentone and 34 +/- 1.4 sec for methohexitone. Ninety-three per cent of the PROP group fell asleep with one dose and required no additional doses. Fifty per cent of each of the THIO and METH groups required additional agents (p less than 0.05). METH was associated with the highest elevation in HR, PROP the least (p less than 0.05). PROP was associated with the most decrease in SBP and DBP and in addition respiratory depression (p less than 0.05). The incidence of injection pain or excitatory activity was equal in the three groups with the exception that 14 patients who received METH developed hiccoughs while none did in the other groups. PROP was associated with the most rapid recovery, particularly with respect to the orientation time. We conclude that PROP is an effective alternative to barbiturate induction and that the published recommended doses of THIO and METH are often ineffective.</description><subject>Adult</subject><subject>Anesthesia Recovery Period</subject><subject>Anesthesia, Intravenous</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Double-Blind Method</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Methohexital - adverse effects</subject><subject>Methohexital - pharmacology</subject><subject>Middle Aged</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenols - adverse effects</subject><subject>Phenols - pharmacology</subject><subject>Propofol</subject><subject>Random Allocation</subject><subject>Respiration - drug effects</subject><subject>Thiopental - adverse effects</subject><subject>Thiopental - pharmacology</subject><issn>0832-610X</issn><issn>1496-8975</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEFLAzEUhIMotVYv3oU9eBJXXzbZzeZYS6tCwYuCtyVNXmxku1mSKPrv3dJSeYeBNx8DM4RcUrijAOL-YQEMKGclPyJjymWV11KUx2QMNSvyisL7KTmL8RMA6qqsR2TEuJQF52Myn2badyn4tkWTue4bY3IfKjnfZd5mffC9t769zdLa-R675DvMVGeyDaa1X-OP237OyYlVbcSLvU7I22L-OnvKly-Pz7PpMteMi5RLXVpgHC2zVCCvjJHAhSh4wXVRK6S2lmCGkwVaYw1aW66wlBpYhdwYNiE3u1wdfIwBbdMHt1Hht6HQbKdo_qcY4Ksd3H-tNmgO6L774F_vfRW1am1QnXbxgNVMFIJX7A9tjma7</recordid><startdate>19870901</startdate><enddate>19870901</enddate><creator>GOLD, M. I</creator><creator>ABRAHAM, E. C</creator><creator>HERRINGTON, C</creator><general>Canadian Anesthesiologists' Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19870901</creationdate><title>A controlled investigation of propofol, thiopentone and methohexitone</title><author>GOLD, M. I ; ABRAHAM, E. C ; HERRINGTON, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-9c5f034ef3f17e46dd904772424c28ae1f890d0d092efdfdeff5be59c036e4dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adult</topic><topic>Anesthesia Recovery Period</topic><topic>Anesthesia, Intravenous</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Double-Blind Method</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Methohexital - adverse effects</topic><topic>Methohexital - pharmacology</topic><topic>Middle Aged</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenols - adverse effects</topic><topic>Phenols - pharmacology</topic><topic>Propofol</topic><topic>Random Allocation</topic><topic>Respiration - drug effects</topic><topic>Thiopental - adverse effects</topic><topic>Thiopental - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GOLD, M. I</creatorcontrib><creatorcontrib>ABRAHAM, E. C</creatorcontrib><creatorcontrib>HERRINGTON, C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Canadian journal of anesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GOLD, M. I</au><au>ABRAHAM, E. C</au><au>HERRINGTON, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A controlled investigation of propofol, thiopentone and methohexitone</atitle><jtitle>Canadian journal of anesthesia</jtitle><addtitle>Can J Anaesth</addtitle><date>1987-09-01</date><risdate>1987</risdate><volume>34</volume><issue>5</issue><spage>478</spage><epage>483</epage><pages>478-483</pages><issn>0832-610X</issn><eissn>1496-8975</eissn><coden>CJOAEP</coden><abstract>This was a randomized study of 180 ASA physical status I and II patients, 60 in each group who received propofol (PROP), 2.5 mg . kg-1, thiopentone (THIO), 4 mg . kg-1, or methohexitone (METH), 1.5 mg . kg-1. Control values, followed by changes after induction and during a 3-min delay before intubation were recorded for the following parameters: heart rate (HR), systolic and diastolic blood pressures (SBP, DBP), respiratory rate (RR), end-tidal CO2 (PETCO2), and induction time (IT). In addition, the incidence of adverse reactions and time for recovery from anaesthesia were noted. The IT (mean +/- SE) was 35 +/- 1 sec for propofol, 35 +/- 1.2 sec for thiopentone and 34 +/- 1.4 sec for methohexitone. Ninety-three per cent of the PROP group fell asleep with one dose and required no additional doses. Fifty per cent of each of the THIO and METH groups required additional agents (p less than 0.05). METH was associated with the highest elevation in HR, PROP the least (p less than 0.05). PROP was associated with the most decrease in SBP and DBP and in addition respiratory depression (p less than 0.05). The incidence of injection pain or excitatory activity was equal in the three groups with the exception that 14 patients who received METH developed hiccoughs while none did in the other groups. PROP was associated with the most rapid recovery, particularly with respect to the orientation time. We conclude that PROP is an effective alternative to barbiturate induction and that the published recommended doses of THIO and METH are often ineffective.</abstract><cop>Toronto, ON</cop><pub>Canadian Anesthesiologists' Society</pub><pmid>3499244</pmid><doi>10.1007/BF03014354</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0832-610X
ispartof Canadian journal of anesthesia, 1987-09, Vol.34 (5), p.478-483
issn 0832-610X
1496-8975
language eng
recordid cdi_crossref_primary_10_1007_BF03014354
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Adult
Anesthesia Recovery Period
Anesthesia, Intravenous
Anesthetics. Neuromuscular blocking agents
Biological and medical sciences
Blood Pressure - drug effects
Double-Blind Method
Heart Rate - drug effects
Humans
Medical sciences
Methohexital - adverse effects
Methohexital - pharmacology
Middle Aged
Neuropharmacology
Pharmacology. Drug treatments
Phenols - adverse effects
Phenols - pharmacology
Propofol
Random Allocation
Respiration - drug effects
Thiopental - adverse effects
Thiopental - pharmacology
title A controlled investigation of propofol, thiopentone and methohexitone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T03%3A28%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20controlled%20investigation%20of%20propofol,%20thiopentone%20and%20methohexitone&rft.jtitle=Canadian%20journal%20of%20anesthesia&rft.au=GOLD,%20M.%20I&rft.date=1987-09-01&rft.volume=34&rft.issue=5&rft.spage=478&rft.epage=483&rft.pages=478-483&rft.issn=0832-610X&rft.eissn=1496-8975&rft.coden=CJOAEP&rft_id=info:doi/10.1007/BF03014354&rft_dat=%3Cpubmed_cross%3E3499244%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/3499244&rfr_iscdi=true